Immunic Press Release
2020-04-24

Immunic, Inc. Announces Pricing of $15 Million Financing

Immunic, Inc. Announces Pricing of…
read more
Aelin Therapeutics Press Release
2020-04-23

Aelin Therapeutics appoints Alexander Scheer, Ph.D., as Chief Scientific Officer

Aelin Therapeutics appoints Alexander Scheer,…
read more
Immunic Press Release
2020-04-22

Immunic, Inc. Reports that IMU-838, a Selective Oral DHODH Inhibitor, Has Demonstrated Preclinical Activity Against SARS-CoV-2 and Explores Plans for a Phase 2 Clinical Trial in COVID-19 Patients

Immunic, Inc. Reports that IMU-838,…
read more
iTeos Press Release
2020-04-03

iTeos Therapeutics Closes $125 Million Series B2 Financing

iTeos Therapeutics Closes $125 Million…
read more
eTheRNA Press Release
2020-03-24

eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

eTheRNA launches an international consortium…
read more
Horama Press Release
2020-03-19

HORAMA Signs Exclusive License Agreement with Leiden University Medical Center Targeting CRB1 Gene Mutations to Treat Inherited Retinal Dystrophies

HORAMA Signs Exclusive License Agreement…
read more
Horama Press Release
2020-03-13

HORAMA strengthens its management team with the appointment of Rodolphe Clerval as Chief Business Officer (CBO)

HORAMA strengthens its management team…
read more
iTeos Press Release
2020-02-28

iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers

iTeos Therapeutics Initiates Phase 1/2 Study…
read more
Minoryx Press Release
2020-01-09

Minoryx Therapeutics receives US FDA fast-track designation for leriglitazone in the treatment of X-ALD

Minoryx Therapeutics receives US FDA…
read more
Novadip Press Release
2019-12-04

Novadip Biosciences to present data at 17th Annual Meeting of the International Federation for Adipose Therapeutics and Science

Novadip Biosciences to present data…
read more